Enlaza Therapeutics: Funding, Investors & Team (Sep 2026)
Enlaza Therapeutics is a biotechnology research company.
Enlaza Therapeutics has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in Sep 2025.
That round is below the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Enlaza Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Enlaza Therapeutics Funding Rounds
Enlaza Therapeutics Founders and Leadership Team
Contact details for the Enlaza Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Enlaza Therapeutics Funding Compared to Other Biotechnology Startups
Enlaza Therapeutics' latest round of $15.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enlaza Therapeutics in Biotechnology and La Jolla
Companies Similar to Enlaza Therapeutics
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Enlaza Therapeutics Funding FAQs
What does Enlaza Therapeutics do?
Enlaza Therapeutics is a biotechnology research company.
How much funding has Enlaza Therapeutics raised?
Enlaza Therapeutics has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in Sep 2025.
When did Enlaza Therapeutics last raise funding?
Enlaza Therapeutics' most recent funding round on record is an undisclosed round of $15.0M, announced in Sep 2025.
Where is Enlaza Therapeutics headquartered?
Enlaza Therapeutics is based in La Jolla, United States.
How many employees does Enlaza Therapeutics have?
Enlaza Therapeutics is in the 51-100 employee band.
How does Enlaza Therapeutics' funding compare to other Biotechnology startups?
Enlaza Therapeutics' latest round of $15.0M is below the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Enlaza Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enlaza Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.